Management strategies for posttransplant hypertension
- PMID: 11152234
Management strategies for posttransplant hypertension
Abstract
Despite recent advances in the prolongation of patient and graft survival, transplant patients continue to die prematurely of accelerated cardiovascular disease. Arterial hypertension is a well-known risk factor for cardiovascular disease morbidity and mortality in the general population and a frequent complication following transplantation. The pathogenesis of posttransplant hypertension in renal transplant recipients is multifactorial and includes pretransplant hypertension in the recipient, donor hypertension, uncontrolled renin secretion from the remaining native kidney, hypertension as a consequence of graft dysfunction, recurrent or de novo renal disease, and, nowadays more rarely, transplant artery stenosis. The strong impact of an immunosuppressive regimen consisting of calcineurin inhibitors and steroids must also be considered. Calcineurin inhibitors and corticosteroids induce hypertension in renal, cardiac, liver, bone marrow, and lung transplant recipients. Posttransplant hypertension appears to be a major risk factor for graft and patient survival. Recent controlled studies support the opinion that posttransplant hypertension must be treated as strictly as in a population with essential hypertension, diabetes mellitus, or chronic renal failure.
Similar articles
-
Nutritional and metabolic issues in solid organ transplantation: targets for future research.J Ren Nutr. 2009 Jan;19(1):111-22. doi: 10.1053/j.jrn.2008.10.020. J Ren Nutr. 2009. PMID: 19121784 Review.
-
Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.Exp Clin Transplant. 2008 Mar;6(1):42-7. Exp Clin Transplant. 2008. PMID: 18405244
-
[Arterial hypertension in renal transplant recipients].Acta Med Croatica. 2007 Apr;61(2):171-6. Acta Med Croatica. 2007. PMID: 17585473 Review. Croatian.
-
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.J Heart Lung Transplant. 2004 May;23(5 Suppl):S187-93. doi: 10.1016/j.healun.2004.03.009. J Heart Lung Transplant. 2004. PMID: 15093804 Review.
-
Hypertension in kidney transplantation.Semin Nephrol. 2005 Jul;25(4):252-60. doi: 10.1016/j.semnephrol.2005.02.009. Semin Nephrol. 2005. PMID: 16202698 Review.
Cited by
-
Effects of late cyclosporine withdrawal on renal graft function and survival.J Nephrol. 2019 Apr;32(2):315-321. doi: 10.1007/s40620-018-0554-7. Epub 2018 Nov 15. J Nephrol. 2019. PMID: 30443763
-
Steroid withdrawal after renal transplantation: a retrospective cohort study.BMC Med. 2017 Jan 12;15(1):8. doi: 10.1186/s12916-016-0772-6. BMC Med. 2017. PMID: 28077142 Free PMC article.
-
Impact of comorbidity on outcome in kidney transplant recipients: a retrospective study in Italy.Intern Emerg Med. 2016 Sep;11(6):825-32. doi: 10.1007/s11739-016-1438-2. Epub 2016 Mar 22. Intern Emerg Med. 2016. PMID: 27003820
-
Metabolic and cardiovascular complications in the liver transplant recipient.Ann Gastroenterol. 2015 Apr-Jun;28(2):183-192. Ann Gastroenterol. 2015. PMID: 25830307 Free PMC article. Review.
-
Ambulatory blood pressure monitoring in pediatric renal transplantation.Curr Hypertens Rep. 2012 Dec;14(6):608-18. doi: 10.1007/s11906-012-0301-8. Curr Hypertens Rep. 2012. PMID: 23011742 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical